IRadimed Corp reports results for the quarter ended in September - Earnings Summary

IRADIMED

03/11/2022 14:26

* IRadimed Corp  IRMD.OQ  reported quarterly adjusted
earnings of
29 cents​​ per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was
for earnings of 25 cents per share.
    * Revenue rose 22.9% to $13.41 million from a year ago;
analysts
expected $13.19 million. 
    * IRadimed Corp's reported EPS for the quarter was 27
cents​.
    * The mean earnings estimate of analysts had fallen by
about 2% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * IRadimed Corp shares had fallen by 9.3% this quarter and
lost 39.8% so far this year.
    * The company reported quarterly net income of $3.43
million.
    * Wall Street's median 12-month price target for IRadimed
Corp is
$42.75 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 02:26 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.25           0.29           Beat
 Jun. 30 2022      0.24           0.26           Beat
 Mar. 31 2022      0.21           0.22           Beat
 Dec. 31 2021      0.21           0.33           Beat